Cardinal Health, Inc. (CAH) managed to eke out gains of 0.52% in intraday trade. The share price increased by 0.39 points to $75.35. Till last observation, the net money flow was recorded at a negative $(-7.04) million. The total inflow of $23.18 million in upticks was completely overshadowed by an outflow of $30.23 million in downticks, giving the up/down ratio a value of 0.77. The shares have seen a change of 3.97% in the past week.A block trade occurred in the company shares in which the composite value of the upticks was $0.75 million and the composite value in downticks was $5.73 million. The resultant up/down ratio for the block exchange was 0.13. The block trade had a negative money flow of $(-4.98) million.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.
Cardinal Health, Inc. has dropped 0.69% in the last five trading days, however, the shares have posted positive gains of 4.7% in the last 4 weeks. Cardinal Health, Inc. is up 10.38% in the last 3-month period. Year-to-Date the stock performance stands at 4.7%. Cardinal Health, Inc. (NYSE:CAH) rose 0.52% or 0.39 points on Wednesday and made its way into the gainers of the day. After trading began at $74.43 the stock was seen hitting $75.39 as a peak level and $74.155 as the lowest level. The stock ended up at $75.35. The daily volume was measured at 2,569,333 shares. The 52-week high of the share price is $87.85 and the 52-week low is $62.7. The company has a market cap of $24,117 million.
Company has reported several Insider transactions to the SEC, on Nov 14, 2016, George S Barrett (Chairman and CEO) sold 217,995 shares at 71.19 per share price.On Aug 22, 2016, Stuart G Laws (SVP & Chief Accounting Officer) sold 9,703 shares at 82.45 per share price.On Aug 22, 2016, Patricia Morrison (Chief Information Officer) sold 43,959 shares at 82.50 per share price.
Cardinal Health Inc Last issued its quarterly earnings results on Oct 31, 2016. The company reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04. Analyst had a consensus of $1.20. The company had revenue of $32039.00 million for the quarter, compared to analysts expectations of $31007.13 million. The companys revenue was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.38 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Cardinal Health Inc was Downgraded by Mizuho on Jan 3, 2017 to Neutral, Price Target of the shares are set at $79.Cardinal Health Inc was Downgraded by Leerink Partners to Mkt Perform on Dec 21, 2016.
Cardinal Health, Inc. is one of the leading providers of products and services to healthcare providers and manufacturers to help them improve the efficiency and quality of healthcare. These services and products include Pharmaceutical Distribution and Provider Services, Medical-Surgical Products and Services, Pharmaceutical Technologies and Services and Automation and Information Services.